Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zelniker TA, Wiviott SD, Raz I, Im K, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 2018 Nov 9. pii: S0140-6736(18)32590.
PMID: 30424892

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016